Skip to main content
All lobbying filings

AMERICAN SOCIETY OF NEPHROLOGY

Lobbying for AMERICAN SOCIETY OF NEPHROLOGY

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $80,000.00 expenses · posted Apr 16, 2026

Official filing document

 Bills named in this filing 6
  • HR 7868
    Expanding Support for Living Donors Act of 2026
  • HR 628
    Honor Our Living Donors Act
  • S 957
    Honor Our Living Donors Act
  • HR 4583
    Living Donor Protection Act of 2025
  • HR 4582
    To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surge…
  • S 1552
    Living Donor Protection Act of 2025
 Lobbying activity 2
Health Issues

-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Raised questions about access to and quality of care in Medicare Advantage plans for kidney patients

Science/Technology

-$51.303B in appropriations for NIH in FY27 (to support investments in basic, clinical, translational, and other health-related research activities) -$1 billion in appropriations for kidney research at NIDDK within the overall NIDDK FY27 appropriation, implementing the recommendations of the Transforming Kidney Health Research report -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem